Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...

Flagship Pioneering-backed Sail Biomedicines has laid off 12 employees following a review of the company’s organizational ...

Biology — the science of life, living things and the processes that keep us all running — links up in essential ways with ...

There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...

Unlike animals, plants do not possess an adaptive immune system with antibodies or T cells to fight viral infections. Instead ...

AIRNA’s lead candidate AIR-001 works by correcting the most common pathologic mutation driving the rare disease alpha-1 ...

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a ...

Colorectal cancer is a serious but preventable disease if detected early. Advances in diagnostics, such as biomarker analysis ...

When the transatlantic startup AIRNA launched in 2023, it was already years behind other companies that were trying to bring ...

Eli Lilly's RNA drug solbinsiran reduced ApoB protein levels by 14.3% in Phase 2 cholesterol trial, competing with ...

A recent study has demonstrated how RNA sequencing can enhance the genetic classification of B-cell precursor acute ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...